bluebird bio Inc (BLUE)
0.3501
+0.05
(+17.52%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.88%)
After-Hours: 20:00
bluebird bio Enterprise Value: 68.02M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 68.02M |
| November 21, 2024 | 57.87M |
| November 20, 2024 | 58.87M |
| November 19, 2024 | 59.27M |
| November 18, 2024 | 64.70M |
| November 15, 2024 | 62.33M |
| November 14, 2024 | 70.45M |
| November 13, 2024 | 73.12M |
| November 12, 2024 | 75.90M |
| November 11, 2024 | 78.54M |
| November 08, 2024 | 78.62M |
| November 07, 2024 | 74.04M |
| November 06, 2024 | 85.16M |
| November 05, 2024 | 87.68M |
| November 04, 2024 | 89.73M |
| November 01, 2024 | 90.31M |
| October 31, 2024 | 89.93M |
| October 30, 2024 | 94.74M |
| October 29, 2024 | 95.32M |
| October 28, 2024 | 95.86M |
| October 25, 2024 | 93.07M |
| October 24, 2024 | 96.73M |
| October 23, 2024 | 99.37M |
| October 22, 2024 | 98.01M |
| October 21, 2024 | 96.29M |
| Date | Value |
|---|---|
| October 18, 2024 | 95.12M |
| October 17, 2024 | 94.29M |
| October 16, 2024 | 93.38M |
| October 15, 2024 | 93.26M |
| October 14, 2024 | 97.55M |
| October 11, 2024 | 98.07M |
| October 10, 2024 | 95.88M |
| October 09, 2024 | 95.84M |
| October 08, 2024 | 94.43M |
| October 07, 2024 | 100.90M |
| October 04, 2024 | 110.48M |
| October 03, 2024 | 100.40M |
| October 02, 2024 | 94.43M |
| October 01, 2024 | 91.23M |
| September 30, 2024 | 100.69M |
| September 27, 2024 | 23.59M |
| September 26, 2024 | 22.25M |
| September 25, 2024 | 18.47M |
| September 24, 2024 | 22.73M |
| September 23, 2024 | 20.58M |
| September 20, 2024 | 16.95M |
| September 19, 2024 | 21.18M |
| September 18, 2024 | 21.76M |
| September 17, 2024 | 22.75M |
| September 16, 2024 | 37.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-292.21M
Minimum
Nov 08 2021
1.593B
Maximum
Jan 17 2020
270.53M
Average
150.65M
Median
Jul 31 2024
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 8.915M |
| Perspective Therapeutics Inc | -31.63M |
| Protalix BioTherapeutics Inc | 97.03M |
| Electromed Inc | 238.10M |
| Armata Pharmaceuticals Inc | 171.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -60.81M |
| Revenue (Quarterly) | 10.61M |
| Total Expenses (Quarterly) | 74.72M |
| EPS Diluted (Quarterly) | -0.31 |
| Gross Profit Margin (Quarterly) | -11.02% |
| Profit Margin (Quarterly) | -573.0% |
| Earnings Yield | -511.3% |
| Normalized Earnings Yield | -507.15 |